Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1251

1.

In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.

Cottagiri M, Nyandjo M, Stephens M, Mantilla J, Saito H, Mackay IR, Rose NR, Njoku DB.

Cell Mol Immunol. 2018 Jul 20. doi: 10.1038/s41423-018-0087-y. [Epub ahead of print]

PMID:
30030493
2.

Emerging predictors of the response to the blockade of immune checkpoints in cancer therapy.

Li X, Song W, Shao C, Shi Y, Han W.

Cell Mol Immunol. 2018 Jul 12. doi: 10.1038/s41423-018-0086-z. [Epub ahead of print] Review.

PMID:
30002451
3.

Failure of a T cell regulator: CD6 contributes to the aggravation of autoimmune inflammation.

Meyer A, Kofler DM.

Cell Mol Immunol. 2018 Jul 12. doi: 10.1038/s41423-018-0089-9. [Epub ahead of print] No abstract available.

PMID:
30002450
4.

Apoptosis inhibitor of macrophage and diabetic kidney disease.

Davis TME, Peters KE, Lipscombe R.

Cell Mol Immunol. 2018 Jul 12. doi: 10.1038/s41423-018-0088-x. [Epub ahead of print] No abstract available.

PMID:
30002449
5.

The methyltransferase PRMT6 attenuates antiviral innate immunity by blocking TBK1-IRF3 signaling.

Zhang H, Han C, Li T, Li N, Cao X.

Cell Mol Immunol. 2018 Jul 4. doi: 10.1038/s41423-018-0057-4. [Epub ahead of print]

PMID:
29973649
6.

The chemokine receptor CCR7 is a promising target for rheumatoid arthritis therapy.

Moschovakis GL, Bubke A, Friedrichsen M, Ristenpart J, Back JW, Falk CS, Kremmer E, Förster R.

Cell Mol Immunol. 2018 Jul 4. doi: 10.1038/s41423-018-0056-5. [Epub ahead of print]

PMID:
29973648
7.

An altered CD8+ T cell epitope of insulin prevents type 1 diabetes in humanized NOD mice.

Zhang M, Wang S, Guo B, Meng G, Shu C, Mai W, Zheng Q, Chen X, Wu Y, Wang L.

Cell Mol Immunol. 2018 Jun 28. doi: 10.1038/s41423-018-0058-3. [Epub ahead of print]

PMID:
29955175
8.

PDCD5 regulates iNKT cell terminal maturation and iNKT1 fate decision.

Wang K, Zhang X, Wang Y, Jin G, Li M, Zhang S, Hao J, Jin R, Huang X, Wu H, Zhang J, Chen Y, Ge Q.

Cell Mol Immunol. 2018 Jun 19. doi: 10.1038/s41423-018-0059-2. [Epub ahead of print]

PMID:
29921968
9.

IL-1 β genesis: the art of regulating the regulator.

Gupta P, Barthwal MK.

Cell Mol Immunol. 2018 Jun 19. doi: 10.1038/s41423-018-0054-7. [Epub ahead of print] No abstract available.

PMID:
29921967
10.

Different domains of β2-glycoprotein I play a role in autoimmune pathogenesis.

Sorice M, Misasi R.

Cell Mol Immunol. 2018 Jun 19. doi: 10.1038/s41423-018-0060-9. [Epub ahead of print] No abstract available.

PMID:
29921966
11.

Interleukin-22 from bench to bedside: a promising drug for epithelial repair.

Gao B, Xiang X.

Cell Mol Immunol. 2018 Jun 19. doi: 10.1038/s41423-018-0055-6. [Epub ahead of print] No abstract available.

PMID:
29921965
12.

B cell development is critically dependent on NFATc1 activity.

Giampaolo S, Wójcik G, Klein-Hessling S, Serfling E, Patra AK.

Cell Mol Immunol. 2018 Jun 15. doi: 10.1038/s41423-018-0052-9. [Epub ahead of print]

PMID:
29907883
13.

Relevance of placental type I interferon beta regulation for pregnancy success.

Kwon JY, Aldo P, You Y, Ding J, Racicot K, Dong X, Murphy J, Glukshtad G, Silasi M, Peng J, Wen L, Abrahams VM, Romero R, Mor G.

Cell Mol Immunol. 2018 Jun 15. doi: 10.1038/s41423-018-0050-y. [Epub ahead of print]

PMID:
29907882
14.

Cortisol facilitates the immune escape of human acute myeloid leukemia cells by inducing latrophilin 1 expression.

Sakhnevych SS, Yasinska IM, Bratt AM, Benlaouer O, Gonçalves Silva I, Hussain R, Siligardi G, Fiedler W, Wellbrock J, Gibbs BF, Ushkaryov YA, Sumbayev VV.

Cell Mol Immunol. 2018 Jun 15. doi: 10.1038/s41423-018-0053-8. [Epub ahead of print] No abstract available.

PMID:
29907881
15.

Ag-specific CD4 T cells promote innate immune responses in liver ischemia reperfusion injury.

Rao J, Cheng F, Yang S, Zhai Y, Lu L.

Cell Mol Immunol. 2018 Jun 15. doi: 10.1038/s41423-018-0051-x. [Epub ahead of print] No abstract available.

PMID:
29907880
16.

Muscle, myeloid cells, and complement: a complex interaction.

Alexander JJ, Quigg RJ.

Cell Mol Immunol. 2018 Jun 5. doi: 10.1038/s41423-018-0049-4. [Epub ahead of print] No abstract available.

PMID:
29872116
17.

Biochemical mechanisms implemented by human acute myeloid leukemia cells to suppress host immune surveillance.

Yasinska IM, Gonçalves Silva I, Sakhnevych S, Gibbs BF, Raap U, Fasler-Kan E, Sumbayev VV.

Cell Mol Immunol. 2018 Jun 5. doi: 10.1038/s41423-018-0047-6. [Epub ahead of print]

PMID:
29872115
18.

MicroRNA-99a mimics inhibit M1 macrophage phenotype and adipose tissue inflammation by targeting TNFα.

Jaiswal A, Reddy SS, Maurya M, Maurya P, Barthwal MK.

Cell Mol Immunol. 2018 May 30. doi: 10.1038/s41423-018-0038-7. [Epub ahead of print]

PMID:
29849090
19.

Cystathionine-γ-lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis.

Wu W, Qin M, Jia W, Huang Z, Li Z, Yang D, Huang M, Xiao C, Long F, Mao J, Moore PK, Liu X, Zhu YZ.

Cell Mol Immunol. 2018 May 29. doi: 10.1038/s41423-018-0037-8. [Epub ahead of print]

PMID:
29844591
20.

Post-transcriptional regulator Rbm47 elevates IL-10 production and promotes the immunosuppression of B cells.

Wei Y, Zhang F, Zhang Y, Wang X, Xing C, Guo J, Zhang H, Suo Z, Li Y, Wang J, Wang R, Cai Z.

Cell Mol Immunol. 2018 May 29. doi: 10.1038/s41423-018-0041-z. [Epub ahead of print]

PMID:
29844590

Supplemental Content

Loading ...
Support Center